(Press-News.org) MIAMI, FLORIDA (Dec. 18, 2023) – Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has been named a fellow of the National Academy of Inventors.
Her research focuses on ways to overcome barriers to precisely target mitochondria – the part of each cell that generates the energy needed for biochemical reactions. Her inventions and innovative contributions in nanomedicine, mitochondria-targeted drug delivery, and platinum-based prodrugs help guide targeted therapies in cancer and other diseases.
Dhar, an associate professor of biochemistry and molecular biology at the University of Miami Miller School of Medicine, is a full member of Sylvester’s Translational and Clinical Oncology Program and co-leader of the Engineering Cancer Cure Program.
She joins Nobel Prize laureates, National Inventors Hall of Fame inductees, National Academies of Sciences, Engineering, and Medicine members, and other accomplished academic inventors in the National Academy of Inventors (NAI) 2023 class of fellows.
“The NAI Fellows Program was established to highlight academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society,” according to the NAI, which is comprised of more than 4,600 members and offers programs that educate, encourage, inspire and recognize academic inventors. “Election to NAI Fellow status is the highest professional distinction accorded solely to academic inventors.”
Dhar’s selection reflects her accomplishments in technologies for mitochondrial nanomedicine and the development of prodrugs with modulated mechanisms of action.
“In many diseases, including cancer, metabolic changes, good and bad, happen in the mitochondria. To get to the mitochondria is difficult because of different barriers,” Dhar said. “The main innovation and focus of my work involve developing programmable systems to effectively reach the mitochondria of a specific cell type.”
Dhar and her team recently worked on an anti-cancer compound to help overcome prostate cancer tumors’ resistance to standard chemotherapy drugs, such as cisplatin. Her team also showed that the compound Platin-L could be loaded in targeted nanoparticles, making the compound available orally. The journal ACS Central Science published the research in July 2023.
Dhar’s innovations go beyond prostate cancer to different cancer types and diseases. Examples include the development of prodrugs for mitochondria-targeted metabolic reprogramming of cancer, the development of orally administrable nanoparticles for viral diseases, and the development of synthetic nanoparticles to replenish lipids to mitochondrial membranes to tackle mitochondrial genetic disorder-mediated diseases.
“Currently, at Sylvester, we are looking at different aspects of cancer that has spread to the brain and how to delay the recurrence of glioblastoma,” Dhar said.
Dhar, who joined Sylvester in 2016 with a vision to promote technology development, said that when she was growing up in India, her father always reminded her that “necessity is the mother of invention.”
“Our main focus growing up in a small town was to try to invent from what we had,” she said. “When I started doing research, my idea was always how to make things simple.”
Dhar began to flourish as an innovator while doing postdoctoral work at the Massachusetts Institute of Technology (MIT), where she focused on nanocarrier-mediated delivery of platinum-based drugs for their potential applications in cancer.
Federal and non-federal funding agencies have awarded Dhar several grants for translational research, and she has received many honors, including a Department of Defense-funded Prostate Cancer Idea Development Award. Her work in developing controlled-release vehicles to target the mitochondria of cells was recognized with the Targeting Mitochondria 2012 Scientific Contribution Award from the World Mitochondria Society.
A fellow of the Royal Society of Chemistry, Dhar was listed in 2019 as one of the top 5% of authors cited in the Royal Society of Chemistry journals. In 2020, she was awarded the University of Miami’s Women in Academic Medicine Trailblazer Award, and the following year, she was inducted into Sigma XI, the scientific research honor society.
The NAI will formally recognize Dhar and other fellows during the NAI Fellows induction ceremony June 18, 2024, during its annual conference in Raleigh, North Carolina.
about Dr. Dhar’s research on the InventUM Blog: https://news.med.miami.edu/dhar-nai-fellow/, and follow @SylvesterCancer on X for the latest in cancer research and care.
# # #
END
Antibiotic-resistant “superbugs” that can defeat efforts to kill them are an urgent public health crisis, and according to the Centers for Disease Control, more than 2.8 million antibiotic-resistant infections occur each year. Researchers across the world are scrambling to meet the challenge. A collaborative team of researchers led by the University of Massachusetts Amherst and including scientists from the biopharmaceutical company Microbiotix recently announced that they had successfully learned how to sabotage a key piece of machinery that pathogens use to infect their host cells, and have developed a test to identify the next-generation drugs ...
Researchers examining the data on opioids for pain caused by cancer have found surprisingly large gaps in evidence regarding the true benefits of these medicines for cancer pain. The review challenges the commonly held view that opioids are the most powerful pain relievers.
The University of Sydney-led review highlights there is no ‘one size fits all’ treatment approach for cancer pain, urging health professionals and patients to carefully weigh up the evidence when deciding on a suitable pain management plan.
Opioid pain relievers are the most common treatment for cancer pain management. Many international guidelines including the ...
Embargoed for release until 5:00 p.m. ET on Monday 18 December 2023
Annals of Internal Medicine Tip Sheet
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.
----------------------------
1. ...
B cell deficiency is a common condition that can result either from immunosuppressant drugs used to treat autoimmune disease or certain cancers — such as rituximab (RTX) — or from natural immune deficiency. These patients suffer from a weakened immune system that is less effective at combating both viral and bacterial diseases. As B cells are a key type of immune cell that produces antibodies, a deficiency results in a significant decrease in antibody count that can lead to severe disease or death upon infection with SARS-CoV-2.
Researchers at the Ragon Institute of Mass General, MIT, and ...
ARLINGTON HEIGHTS, Ill. – (December 18, 2023) — Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in pediatric and adult patients. The Joint Task Force is a partnership between the American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, Asthma and Immunology.
“Both anaphylaxis and atopic dermatitis are allergic conditions that affect millions of people – in the United States and around the world,” says allergist Jay Lieberman, MD, co-chair of the JTFPP ...
New research suggests that air pollution may contribute to the development or worsening of skin conditions.
The work, which is published in Dermatology and Therapy and led by scientists at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system, points to the need to improve air quality to lower the burden of skin disease, especially for vulnerable communities.
“We were inspired to investigate the relationship between air pollution and skin inflammation after listening to patients who kept telling us that their skin conditions like eczema were particularly bad, and in some cases ‘worse than ever before,’ this summer,” ...
“[...] murine models proved to be valuable and, in some cases, indispensable for advancing melatonin applications in oncology [...].”
BUFFALO, NY- December 18, 2023 – A new research perspective was published in Oncotarget's Volume 14 on December 12, 2023, entitled, “Melatonin and carcinogenesis in mice: the 50th anniversary of relationships.”
Fifty years ago, in 1973, Vladimir N. Anisimov and coauthors demonstrated for the first time an inhibitory effect of the pineal ...
New Haven, Conn. — In a new study by researchers at the Yale School of Public Health, two “forever chemicals” spurred cancer cells in the lab to migrate to new positions, an indication that the chemicals could contribute to cancer metastasis in living organisms.
The study addressed the group of industrial chemicals called per- and polyfluoroalkyl substances (PFAS). The substances are known as “forever chemicals” because they don’t break down in the environment and can build up in the human body. They have the ability to shed water and resist penetration by oils. They are ...
Survey Highlights:
A majority of Americans (51%) say it takes them weeks to feel less stressed after the holidays, with more than a quarter of moms reporting it takes them a month or more to recover.
71% of respondents say that their biggest regret after the holidays is that they did not take the time to relax and enjoy the season.
Overall, respondents (63%) claimed that the holiday season is more stressful than tax season.
Eating healthy (69%), exercising regularly (64%), and getting enough sleep (56%) are the top three things that respondents have trouble prioritizing during the holiday season.
79% of people surveyed agree that, during the holidays, they are so focused on creating special ...
Public opinion polls are often considered "the will of the people" but a new study on the role of polls in South Korea shows that they may not always be that transparent.
"Using polls to gauge what people think about politics is not as simple as it sounds, as there are multiple mediating factors between what people think and how their views may be represented in the media," says co-author Sunmin Kim, an assistant professor of sociology at Dartmouth. "Our research shows more broadly, how in a democracy, measuring what people think or want can be a highly haphazard and unpredictable process based on the ways public opinion poll ...
